REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION
批准号:
7885469
负责人:
Anthony R French
金额:
$37.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-15 至 2014-06-30
关键词:
Abnormal CellAddressAdoptive TransferApoptosisAutoimmune DiseasesBiological AssayBiological ModelsC57BL/6 MouseCell ProliferationCell Proliferation RegulationCell SurvivalCellsCytomegalovirusCytomegalovirus InfectionsDataDoseDown-RegulationGene TargetingHerpesviridae InfectionsHomeostasisHost DefenseHumanImmune responseImmune systemIn VitroInfectionInterferon Type IInterleukin-15Knock-outLeadLigandsLymphocyteLymphoproliferative DisordersMalignant NeoplasmsMediatingModelingMolecularMouse StrainsMurid herpesvirus 1MusNK Cell ActivationNatural Killer CellsOrganPhasePhosphorylationPlayPopulationPositioning AttributeProductionProliferatingReceptor ActivationReceptor SignalingRegulationRelative (related person)ResistanceResolutionRoleSTAT5A geneSignal PathwaySignal TransductionSolidT-LymphocyteTYROBP geneViralVirus Diseasesbasecell typechemokinecytokineexperiencein vivokillingsnovel therapeutic interventionpathogenpublic health relevancereceptorresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Natural killer (NK) cells are innate lymphocytes that play a pivotal role in early anti-pathogen host defense and are particularly important in mediating resistance to viral infections. Indeed, humans with selective NK cell deficiencies experience significant difficulty with herpesviruses infections. The ability of NK cells to kill abnormal cells and produce immunomodulatory cytokines and chemokines uniquely positions them to not only participate in the initial defense against intracellular pathogens but also to influence the subsequent adaptive immune response. In addition to killing infected cells and generating cytokines and chemokines, NK cells are stimulated to vigorously proliferate during viral infections. This proliferative response can be divided into three distinct phases: early nonspecific NK cell proliferation, preferential proliferation of NK cells that are able to recognize infected cells, and cessation of proliferation and contraction of the expanded NK cell population. The regulatory mechanisms involved in controlling these different phases of NK cell proliferation are poorly characterized. The long-term objective of these studies is to understand the in vivo regulation of NK cell proliferation and homeostasis during viral infections. Using murine cytomegalovirus (MCMV) infection as a model system, we propose to address several critical, unresolved issues in the in vivo regulation of NK cell proliferation and homeostasis including 1) the relative contributions of cytokines and NK cell activation receptors to viral-induced NK cell proliferation, 2) the mechanism by which NK cell activation receptor signaling augments cytokine-driven NK cell proliferation, and 3) the role of the adaptive immune system in the resolution of viral-induced NK cell proliferation. We contend that a clearer understanding of in vivo NK cell proliferation and homeostasis during viral infections will have broad translational implications and may lead to novel therapeutic interventions to modulate NK cells to either stimulate more effective responses (e.g., during intractable viral infections or solid organ malignancies) or down-regulate over-exuberant or inappropriate responses (e.g., during NK cell lymphoproliferative disorders or autoimmune diseases). Public Health Relevance: Our innate immune system provides early resistance to viral infections while the more specific adaptive immune system is being activated. The overall objective of the proposed studies is to understand the regulation of one important type of cell in our innate immune response, natural killer cells, during viral infections. A more complete understanding of natural killer cell homeostasis during viral infections may lead to new ways to modulate natural killer cell responses during viral infections or autoimmune disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pediatric Infectious Diseases and Immunity Training Program
-
批准号:10187498
-
项目类别:
-
资助金额:$16.1万
-
财政年份:2014
-
负责人:Anthony R French
-
依托单位:
Pediatric Infectious Diseases and Immunity Training Program
-
批准号:10646336
-
项目类别:
-
资助金额:$16.17万
-
财政年份:2014
-
负责人:Anthony R French
-
依托单位:
Pediatric Infectious Diseases and Immunity Training Program
-
批准号:10413963
-
项目类别:
-
资助金额:$15.29万
-
财政年份:2014
-
负责人:Anthony R French
-
依托单位:
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION
-
批准号:8287164
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2009
-
负责人:Anthony R French
-
依托单位:
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION
-
批准号:8964503
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2009
-
负责人:Anthony R French
-
依托单位:
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION
-
批准号:8084144
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2009
-
负责人:Anthony R French
-
依托单位:
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION
-
批准号:7740883
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2009
-
负责人:Anthony R French
-
依托单位:
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION
-
批准号:8486372
-
项目类别:
-
资助金额:$35.01万
-
财政年份:2009
-
负责人:Anthony R French
-
依托单位:
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION
-
批准号:9263748
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2009
-
负责人:Anthony R French
-
依托单位:
INNATE IMMUNE RECEPTOR ANTAGONISM BY ORTHOPOXVIRUS PROTEINS
-
批准号:8130610
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2008
-
负责人:Anthony R French
-
依托单位:
INNATE IMMUNE RECEPTOR ANTAGONISM BY ORTHOPOXVIRUS PROTEINS
-
批准号:7379453
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2008
-
负责人:Anthony R French
-
依托单位:
INNATE IMMUNE RECEPTOR ANTAGONISM BY ORTHOPOXVIRUS PROTEINS
-
批准号:7688579
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2008
-
负责人:Anthony R French
-
依托单位:
INNATE IMMUNE RECEPTOR ANTAGONISM BY ORTHOPOXVIRUS PROTEINS
-
批准号:7922050
-
项目类别:
-
资助金额:$37.62万
-
财政年份:2008
-
负责人:Anthony R French
-
依托单位:
Natural Killer Cell Mediated Control of Vaccinia Virus
-
批准号:7208028
-
项目类别:
-
资助金额:$12.01万
-
财政年份:2004
-
负责人:Anthony R French
-
依托单位:
Natural Killer Cell Mediated Control of Vaccinia Virus
-
批准号:7034499
-
项目类别:
-
资助金额:$11.72万
-
财政年份:2004
-
负责人:Anthony R French
-
依托单位:
Natural Killer Cell Mediated Control of Vaccinia Virus
-
批准号:6906592
-
项目类别:
-
资助金额:$11.44万
-
财政年份:2004
-
负责人:Anthony R French
-
依托单位:
Natural Killer Cell Mediated Control of Vaccinia Virus
-
批准号:6761616
-
项目类别:
-
资助金额:$10.09万
-
财政年份:2004
-
负责人:Anthony R French
-
依托单位:
Immunobiology of the Rheumatic Diseases
-
批准号:10204269
-
项目类别:
-
资助金额:$37.84万
-
财政年份:1977
-
负责人:Anthony R French
-
依托单位:
Immunobiology of the Rheumatic Diseases
-
批准号:10454911
-
项目类别:
-
资助金额:$42.36万
-
财政年份:1977
-
负责人:Anthony R French
-
依托单位:
Immunobiology of the Rheumatic Diseases
-
批准号:10670761
-
项目类别:
-
资助金额:$37.6万
-
财政年份:1977
-
负责人:Anthony R French
-
依托单位:
海外基金